The largest database of trusted experimental protocols

Kinase glo luminescent kinase assay kit

Manufactured by Promega
Sourced in United States

The Kinase-Glo Luminescent Kinase Assay kit is a lab equipment product that measures the activity of kinases. It uses a luminescent signal to quantify the amount of ATP remaining after a kinase reaction, which is proportional to the kinase activity.

Automatically generated - may contain errors

16 protocols using kinase glo luminescent kinase assay kit

1

Measuring AMPK Activity in Cell Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure AMPK activity, AMPK was immunoprecipitated from cell extracts with specific antibodies against the α2-subunits bound to protein G agarose beads. The kinase activity of the immunoprecipitates was measured using SAMS peptide [HMRSAMSGLHLVKRR] and the Kinase-Glo Luminescent Kinase Assay kit (Promega, Madison, USA) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
2

PRPS1/2 Enzyme Activity and Feedback Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
PRPS1/2 enzyme activity and ADP/GDP feedback inhibition of PRPS enzyme activity were performed using a Kinase-Glo luminescent kinase assay Kit (Promega) according to the manufacturer’s instructions as we previously described.12 (link) In brief, 10 μL purified recombinant WT or mutant PRPS1 or PRPS2 with various concentration was incubated in 100 μL of reaction buffer (50 mM Tris, pH 7.5, 10 mM MgCl2, 1 mM DTT, 500 μM ATP, 500 μM R5P, 2 mM phosphate) at 37°C for 1 hours in a 96-well plate. The reaction was terminated by adding 10 μL Kinase-Glo reagent. In GDP feedback inhibition assay, GDP from 6 to 0.25 μM was added in the reaction buffer.
+ Open protocol
+ Expand
3

Enzymatic Activity Determination with ATP

Check if the same lab product or an alternative is used in the 5 most similar protocols
Enzymatic activity was determined at 70 °C by measuring the increase in the amount of product ATP using the Kinase-Glo Luminescent Kinase Assay kit (Promega, Tokyo, Japan). The assay solution contained 50 mM MOPS (pH 5.5–6.5) or HEPES (pH 6.5–8.5), 25 mM KCl, 10 mM (NH4)2SO4, 2.0 mM Mg(CH3COO)2, 1.0 mM dithiothreitol, 5.0 mM ADP, and 5.0 mM GTP. One unit of enzyme activity was defined as the formation of 1 μmol of ATP per minute.
+ Open protocol
+ Expand
4

ATP Hydrolysis Kinase Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
ATP hydrolysis activity was evaluated using the Kinase Glo Luminescent Kinase assay kit (Promega). Beads prepared as described above were distributed in increasing quantities in white 96-well plates in washing buffer (20 mM Tris pH 7.5, 1 mM DTT, 200 µM activated sodium orthovanadate, Roche cOmplete EDTA-free anti-protease cocktail) to 20 µL per well. ATP buffer (washing buffer containing 3.3 µM ATP, 16.7 µg/mL MBP and 3.3 mM MgCl2) was then added to a final volume of 50 µL per well. JNK1 was used as a kinase positive control. After incubation at 37 °C for 2 h shaking at 54 rpm in the dark, Glo reagent equilibrated to room temperature was added (50 µL per well) and the plate was incubated shaking at 100 rpm for 10 min in the dark at room temperature before measuring the luminescence on a TECAN Spark 10 M luminometer (see Supplementary Table S4 for raw data).
+ Open protocol
+ Expand
5

CDC7 Kinase Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Kinase-Glo® luminescent kinase assay was used to screen compounds for activity against CDC7. Human recombinant full-length CDC7/DBF4 kinase, substrate PDKtide (KTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC) and reaction buffer was purchase from Promega (CDC7/DBF4 Kinase Enzyme System, Cat#: V5088, Promega Biotech Ibérica, SL). The enzymatic reaction was performed in a total volume of 40 µL in white 96-well plates. In a typical assay, 10 µL of test compound at a final concentration of 10 µM, 10 µL of enzyme solution (25 ng/well), 10 µL of ATP solution (1 µM/well) and 10 µL of PDKtide substrate (0.2 µg/µL/well) were added to each well. The final DMSO concentration in the reaction mixture did not exceed 1%. After 60-min shake-incubation period, the enzymatic reaction was stopped with 40 µL of Kinase-Glo reagent (Kinase-Glo® Luminescent Kinase Assay kit, Cat#: V6711, Promega Biotech Ibérica, SL). Glow-type luminescence was recorded after 10 min using a GloMax® Discover Microplate Reader (Promega Biotech Ibérica, SL). The activity is proportional to the difference of the total and consumed ATP. The inhibitory activities were calculated based on maximal activities measured in the absence of inhibitor.
+ Open protocol
+ Expand
6

Measuring CMPK1 Activity with GSK983

Check if the same lab product or an alternative is used in the 5 most similar protocols
The activity of recombinant human CMPK1 was measured in the presence of GSK983 using an ATP consumption assay. CMPK1 (10 nM) was added to a reaction buffer containing Tris (50 mM, pH 7.5), MgCl2 (2 mM), DTT (2 mM), ATP (100 μM), CMP (100 μM), and GSK983 (0–10 μM, from a DMSO stock solution). The final concentration of DMSO in all reaction mixtures was 2% (v/v). Enzyme activity assays were conducted at 37 °C. The consumption of phosphoryl donor ATP was monitored using a Promega Kinase-Glo Luminescent Kinase Assay kit according to the manufacturer’s instructions. We observed no effect of GSK983 on CMPK1 activity in vitro at GSK983 concentrations up to 10 μM.
+ Open protocol
+ Expand
7

Kinase Inhibitor Potency Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
According to the manufacturer's instructions, kinase activity was measured using the Kinase-Glo Luminescent Kinase Assay kit (Promega, Madison, WI, USA). Recombinant ROCK1 (Carna Biosciences, Kobe, Japan) was incubated with various concentrations of ROCK inhibitor in binding buffer (0.05 M Trizma hydrochloride buffer [pH 7.5] containing 0.1 M KCl, 0.01 M MgCl2, 0.1 mM EGTA, 30 mmol/L long S6 kinase substrate, and 1 mmol/L ATP) at room temperature for 90 minutes. The SSBK-LanthaScreen binding assay against MYLK4 and the SSBK-Z’-LYTE kinase-binding assay against mitogen-activated protein kinase kinase kinase 19 (MAP3K19 and YSK4) were both used with the manufacturer's protocol (Thermofisher Scientific, Waltham, MA, USA). To calculate half-maximal inhibitory concentration (IC50), nonlinear regression, sigmoidal dose-response (variable slope) curves were plotted using GraphPad Prism version 5.0 (GraphPad Software, San Diego, CA, USA).
+ Open protocol
+ Expand
8

Kinase Activity Measurement via Luminescent Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
This assay is more accurate for measuring higher protein kinase activities as it directly measures the consumption of co-factor ATP during the phospho-transfer. Kinase-Glo® Luminescent Kinase Assay kit was purchased from Promega. The primary reaction consisted of the kinase, substrate and ATP in 60 mM HEPES, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 μM Na2VO4, 1.2 mM DTT and 0.05 mg/ml BSA. After 1 h of incubation at 30°C, 20 μL of Kinase-Glo® Reagent was added and mixed at room temperature for 10 min, and luminescence was measured on a GloMax® 96 microplate luminometer (Promega). All the kinases used were purchased from ProQinase. For GSK3β we used 140 ng of kinase, 1 μg of GSM (Millipore), or 1 μg of SRPK1, and 1 μM ATP. For each kinase reaction, control reactions were made without substrate or without kinase. 500 μM ibuprofen (Sigma-Aldrich) was added to the reactions, using DMSO as control. As specific inhibitor for GSK3β we used 10 μM CHIR99021 (BioVision). Note that all the above conditions included also 25 μM SRPIN340 (kindly provided by Dr. Masatoshi Hagiwara) in order to inhibit SRPK1 kinase activity.
+ Open protocol
+ Expand
9

ATPase Activity Quantification of UspE

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in vitro ATPase activity of UspE was measured by quantifying the amount of ATP remaining in the solution following a kinase reaction using a Kinase-Glo® Luminescent Kinase Assay Kit (Promega, Fitchburg, WI, USA). The assay was performed in a 96-well plate in a kinase reaction volume of 50 μl containing 10 mM MgCl2,5 μM ATP,10 mM HEPES (pH 8.0) and 150 mM NaCl. The reaction was initiated by adding the protein to a final concentration of 0.4 mg/ml-3.2 mg/ml. The reaction mixture was kept at 310 K for 20 min in a water bath. Reaction mixtures containing no UspE were used as negative controls. The kinase reaction mixture was incubated with 50 μl of ATP detection reagent. The plates were then incubated for another 10 min at 310 K. The Synergy2 Multi-Mode Microplate Reader (BioTek, Winooski, VT, USA) was used to collect the relative light unit (RLU) signal. The luminescent signal was positively correlated with the amount of remaining ATP and inversely correlated with the amount of kinase activity.
+ Open protocol
+ Expand
10

Measuring CMPK1 Activity with GSK983

Check if the same lab product or an alternative is used in the 5 most similar protocols
The activity of recombinant human CMPK1 was measured in the presence of GSK983 using an ATP consumption assay. CMPK1 (10 nM) was added to a reaction buffer containing Tris (50 mM, pH 7.5), MgCl2 (2 mM), DTT (2 mM), ATP (100 μM), CMP (100 μM), and GSK983 (0–10 μM, from a DMSO stock solution). The final concentration of DMSO in all reaction mixtures was 2% (v/v). Enzyme activity assays were conducted at 37 °C. The consumption of phosphoryl donor ATP was monitored using a Promega Kinase-Glo Luminescent Kinase Assay kit according to the manufacturer’s instructions. We observed no effect of GSK983 on CMPK1 activity in vitro at GSK983 concentrations up to 10 μM.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!